MITOMYCIN, IFOSFAMIDE, AND MESNA IN THE TREATMENT OF LUNG-CANCER

被引：0
|
作者：
DORR, RT
机构：
来源：
SEMINARS IN ONCOLOGY | 1990年 / 17卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2 / 5
页数：4
相关论文
共 50 条
  • [21] DOSE-FINDING STUDIES WITH CARBOPLATIN, IFOSFAMIDE, ETOPOSIDE, AND MESNA IN NON-SMALL CELL LUNG-CANCER
    VANZANDWIJK, N
    HUININK, WWT
    WANDERS, J
    SIMONETTI, G
    DUBBELMAN, R
    FRANKLIN, H
    VANTINTEREN, H
    MCVIE, JG
    SEMINARS IN ONCOLOGY, 1990, 17 (01) : 16 - 19
  • [22] IFOSFAMIDE IN SMALL CELL LUNG-CANCER
    EINHORN, LH
    SEMINARS IN ONCOLOGY, 1989, 16 (01) : 19 - 21
  • [23] DOSE-FINDING STUDIES WITH CARBOPLATIN, IFOSFAMIDE, ETOPOSIDE AND MESNA IN NON-SMALL CELL LUNG-CANCER
    VANZANDWIJK, N
    HUININK, WWT
    WANDERS, J
    SIMONETTI, G
    DUBBELMAN, R
    FRANKLIN, H
    BROUWER, M
    MCVIE, JG
    IFOSFAMIDE IN THE TREATMENT OF LUNG CANCER, 1989, 35 : 119 - 121
  • [24] The effect of ifosfamide and mesna in the treatment of children with various types of cancer
    Hashemi, Azam Sadat
    Sheikhpour, Elnaz
    Ghanizadeh, Fatemeh
    Bahrami, Mahshid
    IRANIAN JOURNAL OF PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2022, 12 (04) : 214 - 219
  • [25] Oral ifosfamide/mesna versus intravenous ifosfamide/mesna in non-small-cell lung cancer: A randomized phase II trial of the EORTC lung cancer cooperative group
    Manegold, C
    Drings, P
    Pawinski, A
    Lentz, MA
    vanGlabbeke, M
    vanZandwijk, N
    Bachmann, P
    Schnaars, Y
    Skacel, Z
    Zatloukal, P
    Dolensky, J
    Jackevicius, A
    Petruzelka, L
    Giaccone, G
    ANNALS OF ONCOLOGY, 1996, 7 (06) : 637 - 639
  • [26] IFOSFAMIDE AND MESNA IN THE TREATMENT OF MALIGNANT DISEASE MESNA AS UROTHELIAL PROTECTOR
    FALKSON, CI
    FALKSON, HC
    FALKSON, G
    INVESTIGATIONAL NEW DRUGS, 1989, 7 (2-3) : 261 - 267
  • [27] TREATMENT OF IFOSFAMIDE-INDUCED UROTHELIAL TOXICITY BY ORAL-ADMINISTRATION OF SODIUM 2-MERCAPTOETHANE SULFONATE (MESNA) TO PATIENTS WITH INOPERABLE LUNG-CANCER
    ARAUJO, CE
    TESSLER, J
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1983, 19 (02): : 195 - 201
  • [28] PHASE-II TRIAL IN ADVANCED NON-SMALL CELL LUNG-CANCER WITH IFOSFAMIDE, MITOMYCIN AND CISPLATINUM
    GIRON, CG
    BARON, MG
    GALLEGO, AO
    BATLLE, JF
    DURAN, AS
    IFOSFAMIDE IN THE TREATMENT OF LUNG CANCER, 1989, 35 : 127 - 138
  • [29] PHASE-II STUDY WITH MITOMYCIN, IFOSFAMIDE AND CARBOPLATIN IN INOPERABLE NON-SMALL-CELL LUNG-CANCER
    VONROHR, A
    ANDERSON, H
    MCINTOSH, R
    THATCHER, N
    EUROPEAN JOURNAL OF CANCER, 1991, 27 (09) : 1106 - 1108
  • [30] TREATMENT OF SMALL-CELL LUNG-CANCER WITH VP-16 AND IFOSFAMIDE
    WESTERHAUSEN, M
    WELLENS, W
    MUSSGNUG, G
    SCHAFER, E
    HABETS, L
    PRAXIS UND KLINIK DER PNEUMOLOGIE, 1981, 35 : 902 - 904
12345